XW: Formal Analysis, Funding acquisition, Supervision, Validation, Writing review and editing
There's no doubt that Roche is playing catchup in the category, one of a lengthening list of pharma companies that are hoping to hit on effective 'me-too' products that can make a dent in the substantial lead held by market leaders Novo Nordisk and Eli Lilly, which already have injectable GLP-1s for diabetes and obesity on the market
The cagrilintide and retatrutide combination has generated interest because amylin receptor agonism addresses appetite through yet another independent pathway
1 yrCN4.3/5.0 20% Reorder rate 240 Interested customers 3/3 Matches all K Beauty Glutathione Salmon PDRN Hyaluronic Vitamin C Tranexamic Glow Skin Booster Serum Korean Skincare OEM $50 Min
68 (Supplement 1)
While semaglutide, such as Rybelsus, is not yet directly linked to this condition, the drugs role in managing diabetes may impact a persons risk